Vitamin B,, is an essential nutrient for the flagellate Prymnesium parvum when growing in axenic culture and apparently can be replaced only by a few related 'incomplete' analogues, i.e. only those devoid of one or both benzimidazole-methyl groups ; and, of the substituted analogues, some (e.g. the mono-acid, the dicarboxylic acid and the ethylamide of B,,) can replace vitamin B,,, but some others of this group, e.g. pseudovitamin B,,, 2-methylmercaptoadenine cobamide, the ethylamide mono-acid, methylamide and anilide of the vitamin B,, , act as competitive inhibitors of the growth of P. parvum.
INTRODUCTION
Micro-organisms which respond to vitamin B,, as a nutrient may be divided into three groups in accordance with their ability to accept some other metabolite in place of vitamin B,, (Lascelles & Cross, 1955) . In the present paper vitamin B,, means a-( 5,6-dimethyl benzimidazoly1)-cobamide cyanide. The first group comprises a mutant of Escherichia coli for which methionine may replace vitamin B,, (Davis & Mingioli, 1950) . The second group, comprising several lactobacilli, can have vitamin B,, replaced by certain deoxyribosides and purines (Kitay, McNutt & Snell, 1950) . To the third group belong micro-organisms such as Ochromonas malhumensis, whose vitamin B,, requirement can only be satisfied by the vitamin itself or by some of its analogues (Ford, 1958) . These micro-organisms may alternatively be divided into three groups, each with its own specific requirements in relation to the vitamin B,, group (Kon & Pawelkiewicz, 1958) . To the first group belongs Escherichia coli 113-3, which can satisfy its vitamin B,, requirements not only by the benzimidazole and purine analogues but also by 'incomplete' analogues devoid of the nucleotide. The second group is represented by Lactobacillus leichmanii and Euglena gracilis; members of this group utilize vitamin B,, and its benzimidazole or purine analogues. The third group includes Ochromonas malhamensis, which can utilize only the benzimidazole analogues, Prymnesium parvum (Chrysomonadina) has been shown to require vitamin B,, for its growth in axenic culture (Droop, 1954a; Rotberg, 1958) ; McLaughlin (1958) tested the specificity of its requirement for some of the B,, analogues. In the present paper, an attempt has been made to determine the position of P. parvum within the aforementioned scheme by studying its specific vitamin B,, requirements.
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Some of the B,, analogues are known to inhibit the growth of various microorganisms (Ford, 1958 (Ford, , 1959 Baker, Frank, Pasher, Hutner & Sobotka, 1960) ; these analogues were also tested for their effect on the growth of P. parvum.
METHODS
Of the two strains of Prymnesium parvum isolated, respectively, by Droop (1954 b) and by Reich & Kahn (1954), the latter (Reich) strain has been used in this study.
Cultures of P. parvum were grown in a simplified version of a culture medium for marine algae (Provasoli, McLaughlin & Droop, 1957) , the composition of which is shown in Table 1 .
Stock cultures of Prymnesium plurvum were maintained on basal medium fortified with suboptimal quantities (10 ppg./ml.) of vitamin B,,. In some of the experimental cultures, however, vitamin B,, was intentionally omitted. All cultures were grown in 16 x 160 mm. test tubes fitted with aluminium caps to prevent possible organic contamination. Inoculation was accomplished by transferring 0.1 ml. of a 10-to 12-day culture into 5 ml. of basal medium containing the substances to be tested. The cultures were kept in a thermostat under constant illumination a t 20 & 2'. Growth measured as optical density ( o.D.) was determined after incubation for 12 days with a Junior Coleman Spectrophotometer at 480 mp. Control cultures of P. parvum, grown in basal medium + 100 ppg. vitamin BI2/m1., attained a count of about 5 x lo6 organisms/ml.
The various compounds of the vitamin B,, group to be tested (Table 2) were kept sterile in solution in sealed glass ampoules, and were added to the medium before autoclaving.
RESULTS
The nutrient requirement of Prymnesium parvum satisfied by vitamin B,, could not be replaced by various amounts of DNA, RNA, thymidine, thymine, deoxyadenosine, adenosine, cytidine, guanosine or uridine. Attempts to stimulate the growth of Prymnesium parvum in the absence of vitamin B,, by addition of various amino acids, such as alanine, glycine, homocysteine, homocystine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, serine, threonine, tryptophan or valine, were unsuccessful; negative results were obtained also with betaine or Table 3 shows growth of P. parvum in media containing 'incomplete' analogues of vitamin B,, in which some part of the molecule is missing.
As seen from Table 4 , the remaining vitamin B,, analogues fell into two groups with respect to their influence on the growth of P . parvum. Members of the one 12.5 25 50 I00 100~000 ppg./mI. analog. Fig. 1 group, namely FIIIm, MO, DA and EA, replaced the vitamin quantitatively; however, each of these analogues elicited a different growth response (Fig. l) .
The second group of analogues included FA, PVB,,, 2MMA Cob, FIII, EAM, MA and An; these had an inhibitory effect on the growth of Prymnesium parvum even in the presence of vitamin B,,. Since it had been claimed by Droop, McLaughlin, Pintner & Provasoli (1959) that F I11 replaces vitamin B,, for P. parvum, an attempt was made to compare the growth of the 'Droop' and the 'Reich' strains in the presence of this analogue. Such comparison showed that both strains reacted in similar fashion to compound FIII, the growth of both being inhibited by this The inhibitory analogues were further tested quantitatively for their inhibitory effect. For this, two parallel series of media were used: the first series contained 100 ppg. vitamin B,,/ml., while the amount of the analogue tested varied successively from a ratio of analogue/B,, of 1 : 1 to 10,000 : 1 (w/w), except for PVB,, and 2MMA Cob, for which the ratios were from 31-25: 1 to 500: 1 (unbroken line in Fig, 2) . Media of the second series contained 1 pg. analogue/ml., with the exception of PVB,, and 2MMA Cob, of which 50 mpg./ml. were given, while the amount of vitamin B,, varied according to the desired ratio (broken line in Fig. 2 ).
From Fig. 2 it is clear that, in a medium containing both vitamin B,, and the inhibitory analogues, the growth of P. parvum was dependent on the ratio of analogue to vitamin B12 and not on the absolute amount of inhibitor. From the above figures, the inhibition indices of the various analogues may be roughly estimated; their approximate values are given in Table 5 . Table 2 .
DISCUSSION
The nutrient requirement of Prymnesium parvum for vitamin B,, is very exacting. Vitamin B,, was not replaced by any of the various unrelated metabolites tested, nor could the 'incomplete' analogues substitute for it. These facts a t once place P. parvum among the most exacting of the micro-organisms which have a nutrient requirement satisfied by vitamin B,,. Furthermore, P. parvum is apparently incapable of synthesizing vitamin B,, even when some of the preformed parts of this vitamin are supplied. On the other hand, analogues which lack one or both of the benzimidazole methyl groups can substitute for vitamin B,,. This could be explained by assuming either that P. parvuwb is capable of adding the missing methyl groups to analogues such as benzimidazolyl cobamide cyanide, or that the function of vitamin B,, is not affected by the absence of these groups. The former assumption seems the more plausible, since compound F 111,, which has a methoxybenzimidazole group, replaced vitamin B12, whereas compound F 111, with an hydroxybenzimidazole group at the same site, inhibited growth. Analogues in which a purine replaces the benzimidazole of the vitamin B,, molecule, such as compounds FA, 2MMA Cob and PVB,,, all inhibited growth. This indicates that the benzimidazole part of the molecule is essential for the normal function of vitamin B,, in P. parvum.
There are conflicting reports in the literature about the influence on the growth of micro-organisms of analogues substituted in the propionamide groups of the corrinoid part of the vitamin B,, molecule. Thus, analogue MO (B12 monoacid), which can replace vitamin B,, for Prymnesium parvum, was reported by Baker et al. (1960) to do the same for Ochromovm malhamensis. Ford (1959), however, found it inhibitory for the growth of 0. malhamensis. Such discrepancy in the data for 0. malhamensis is found also with regard to analogue MA (vitamin B,, methylamide), which inhibited the growth of P. parvum. Ford (1959) found that 0. malhamensis adapts to the utilization of the inhibitory MA, or thatvigorously growing cultures can probably transform this analogue to vitamin BI2. Analogues Prymnesium parvum and vitamin B,, 201 DA (B,, dicarboxylic acid) and EA (B,, ethylamide), which are inhibitory for 0. malhamensis (Ford, 1959; Baker et aZ. 1960) , were in the present study able to substitute for vitamin B,,. Such contradictory results may be attributable either to differences in the experimental procedures used and their effect on the analogues, or to differences in ability of the given micro-organism to take up the analogues and change them to the functional forms. As the coenzyme forms of B,, are known to contain different analogues (Barker, Barker et al. 1960b) , it follows that a micro-organism's requirements for a given coenzyme form can determine the respective influence of the analogues on its growth. Further work on the particular function of each analogue is therefore desirable. The inhibitory effect of analogues of vitamin B,, on the growth of Prymnesium pamum has, in the present work, been shown to depend on the ratio of analogue to vitamin B,, in the culture medium and not on the absolute amount of analogue. This indicates a form of competitive inhibition, with analogue and vitamin competing for a particular enzyme site in P. parvum. However, as pointed out by Woolley (1952), 'the inhibition index as found in a living organism may represent the resultant of several forces rather than the relative affinity of the two compounds for a specific protein'.
